Tag: Vaccines
42.4 Percent of U.S. Teens Have Received at Least One COVID-19 Shot
Vaccination coverages vary by state, with rates of one dose or more ranging from from 20.2 percent in Mississippi to 70.1 percent in Vermont
Vaccines’ Power Against COVID-19 Hospitalization Fades in Elderly
Hospitalization rates among fully vaccinated higher among older residents of nursing homes and among those with underlying conditions
CDC Recommendations for Influenza Vaccination Updated for 2021-2022
ACIP makes no preferential recommendation when more than one licensed, recommended vaccine is available
COVID-19 Vaccine Hesitancy Up for Racial, Ethnic Minority HCWs
Vaccine hesitancy highest among Black and Hispanic or Latino health care workers; concerns include side effects, newness of vaccine
Adverse Events Associated With BNT162b2 Vaccination ID’d
Vaccination not associated with elevated risk for most of the adverse events examined; association found with increased risk for myocarditis, but risk higher in association with SARS-CoV-2 infection
Physician’s Briefing Weekly Coronavirus Roundup
Half of American Workers Support COVID-19 Vaccination, Mask Mandates in Workplace
Poll was conducted before the FDA granted full approval to the Pfizer COVID-19 vaccine
SARS-CoV-2 Shot Continues to Prevent Infection, Hospitalization With Delta Variant
SARS-CoV-2 infection rate and hospitalization rate 4.9 and 29.2 times higher for unvaccinated versus fully vaccinated persons
Moderna Readies for Full Vaccine Approval, as Pfizer Submits Data on Booster Shot
Right now, Moderna vaccine only authorized for emergency use in Americans 18+ years; Pfizer boosters available to immunocompromised
Risk for Bell Palsy Up 42 Days After First Dose of CoronaVac
Hong Kong study shows small increased risk after Sinovac Biotech vaccine, but no significantly increased risk after BNT162b2 vaccine
